Publication | Closed Access
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
15
Citations
16
References
2020
Year
MedicinePharmacologyPathologyAdvanced Solid TumorsMtor InhibitorAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1